THE ultimate warrior would be unable feel fear or pain, capable of running at Olympic speeds, and even immune to modern weapons.
Their existence was once only possible in the realm of science fiction but a new worldwide arms race is pitting nation states against each other to be the first to successfully create real genetically modified super soldiers.
Militaries have a long history of using powerful drugs to temporarily turn their troops into transcendant Terminator-style killers.
Nazis took methamphetamine or "crystal meth" during the Second World War to stay alert and awake for superhuman stretches of time.
And even the British military bought thousands of Modafinil pills which boost brain-power ahead of the Iraq War.
In China, it is reasonable to assume that they are enhancing their battlefield soldiers on all these fronts.
But with advances in technology, it could now be possible to alter soldiers' DNA to give them godlike powers all the time, from Herculean strength to lizard-like limb regeneration.
GM technology is proven with plants, it could absolutely be applied to the person, said Professor John Louth, an expert at defence think tank Rusi.
In China, it is reasonable to assume that they are enhancing their battlefield soldiers on all these fronts.
China's armed forces are the largest in the world, consisting of a staggering 2.2million personnel.
This year alone, Beijing is spending $178.16billion on its defence budget.
But as the country's international relations flare up, they could be looking to be the first army to have genetically modified super soldiers to get ahead of adversaries.
5
These combatants would be stronger, faster and even smarter than their battlefield opponents.
Their DNA could also be adapted to help them recover more quickly from injuries or give them superior hearing and night vision.
The threat is obvious and real. Chinese money could be stealing a march on western armed forces and that is deeply concerning," Prof Louth said.
Concerns about China's super soldier plans came after a Chinese scientist, He Jiankui, claimed to have successfully created genetically modified babies using gene editing technology.
5
5
China jailed Dr Jiankui for illegal medical practices over his claims to have made three babies immune to HIV.
But it's now suspected that Chinese military chiefs are backing trials into human gene editing.
But they're not alone.
The US has also conducted some strange super-soldier research projects.
They've already publicly unveiled a 5million Iron Man-style exoskeleton which gives fighters incredible muscle-power.
5
And the Defense Advanced Research Projects Agency (DARPA) developed ways for warfighters to scale walls by studying the skin of geckos.
Novelist Simon Conway, who was granted behind-the-scenes access at the secretive Pentagon agency, revealed a string of other super soldier programmes underway there in 2012.
He claims scientists were working on gene modification that would allow soldiers' bodies to convert fat into energy more efficiently, allowing them to go days without eating.
What is gene editing?
"It's all about improving the efficiency of energy creation in the body," Conway told the Sunday Express.
"Soldiers would be able to run at Olympic speeds, carry large weights and go without sleep and without food."
But the US isn't just looking at how biotechnology can give their soldiers the upper-hand on the battlefield.
They're also carrying out research into medical regeneration, allowing severely injured soldiers who've lost limbs or suffered extensive burns to heal organically.
This is already a reality in the animal kingdom, where lizards can regrow amputated tails and salamanders can restore entire severed limbs.
"We would like it to be as restorative as possible, resist infection and be durable," said Army Lt. Col. David Saunders, extremity repair product manager for the U.S. Army Medical Materiel Development Activity.
"[There are] many wonderful things emerging in the field of regenerative medicine to restore form and function to our wounded warfighters."
As recently as January 2020, the US military was unveiling incredible advances in warzone genetics.
5
Army researchers developed a gene therapy that allowed mice to create proteins that would protect them against nerve agents deadly chemical weapons that attack the nervous system, like the Russian Novichok used in the Salisbury poisonings in 2018.
The same gene therapy given to the mice that made them chemical weapon-proof could theoretically be used in soldiers entering hazardous environments.
Before Russia's nerve agents were used with terrible effect, president Vladimir Putin had warned of an even more terrifying weapon.
Speaking at a 2017 youth festival in Sochi, Putin spoke openly about the destructive possible consequences of gene-editing.
"A man has the opportunity to get into the genetic code created by either nature, or as religious people would say, by the God," he said, The Express reports.
"He can be a genius mathematician, a brilliant musician or a soldier, a man who can fight without fear, compassion, regret or pain.
"As you understand, humanity can enter, and most likely it will in the near future, a very difficult and very responsible period of its existence.
"What I have just described might be worse than a nuclear bomb."
But instead of this being something in the "near future", Russia is already factoring genetics into its military strategy.
Alexander Sergeyev, the head of the country's Academy of Sciences, revealed the armed forces were researching "genetic passports" in 2019, Forbes reports.
The passports would predict a soldier's "resistance to stress, ability to perform physical and mental operations under the conditions of this stress, and so on."
Sergeyev added that they could be used to sort which branch of the armed forces personnel would be sent to.
"There are already serious developments in this area," he said.
"It is about understanding at the genetic level who is more prone to, for example, to service in the fleet, who may be more prepared to become a paratrooper or a tankman."
What I have just described might be worse than a nuclear bomb.
And unlike other world leaders, Putin has a very close interest in genetic editing.
That's because his eldest daughter, Maria Vorontsova, is a scientist who specialises in genetic engineering and acts as his adviser on the matter.
In 2018, before He Jiankui revealed his HIV-immune babies in China, Putin had already allotted $2billion for genetic research, Bloomberg reports.
INK AGAINBored tattoo lovers do their OWN DIY inkings - and even Kaia Gerber's a fan
Comment
Leo McKinstryTories must keep a tight grip on spending or risk a return to misery of 1970s
PAIN IN SPAINInside Costa Del Sol's bloody gang wars as thugs dish out 'medieval' torture
WHO CARES WINSInside wobble rooms where nurses & doctors go to escape Covid trauma
Exclusive
CYBER CRIMEWe're 'armchair detectives' investigating grim cold cases from our own homes
He even put Vorontsova in charge of the 30-person panel overseeing the experiments.
Watching world superpowers will undoubtedly be paying attention to Putin's potential to weaponise the research.
After all, as Putin says, genetic editing is an area of science which will "determine the future of the whole world".
- Clemson professor Trudy Mackay elected to the National Academy of Medicine - Clemson News - October 22nd, 2024
- Research sheds new light on the behavior of KRAS gene in pancreatic and colorectal cancer - News-Medical.Net - October 22nd, 2024
- Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon - Nature.com - October 22nd, 2024
- Tailored Genetic Medicine: AAV Gene Therapy and mRNA Vaccines Redefine Healthcare's Future - Intelligent Living - October 22nd, 2024
- The Genetic Link to Parkinson's Disease - Hopkins Medicine - August 27th, 2022
- Epic Bio makes gene therapies by editing the epigenome - Labiotech.eu - August 27th, 2022
- Ovid turns to gene therapy startup to restock drug pipeline - BioPharma Dive - August 27th, 2022
- Whole-exome analysis of 177 pediatric patients with undiagnosed diseases | Scientific Reports - Nature.com - August 27th, 2022
- First Gene Therapy for Adults with Severe Hemophilia A, BioMarin's ROCTAVIAN (valoctocogene roxaparvovec), Approved by European Commission (EC) -... - August 27th, 2022
- Arbor Biotechnologies Enters into Agreement with Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in Rare Liver Diseases - BioSpace - August 27th, 2022
- ElevateBio Partners with the California Institute for Regenerative Medicine to Accelerate the Development of Regenerative Medicines - Business Wire - August 27th, 2022
- ElevateBio and the University of Pittsburgh Announce Creation of Pitt BioForge BioManufacturing Center at Hazelwood Green to Accelerate Cell and Gene... - August 27th, 2022
- Genetic variants cause different reactions to psychedelic therapy - The Well : The Well - The Well - August 27th, 2022
- Personalized Medicine for Prostate Cancer: What It Is and How It Works - Healthline - August 27th, 2022
- Four radical new fertility treatments just a few years away from clinics - The Guardian - August 27th, 2022
- Why are Rats Used in Medical Research? - MedicalResearch.com - August 27th, 2022
- The Columns Stepping Stones in STEM Washington and Lee University - The Columns - August 27th, 2022
- Study points to new approach to clearing toxic waste from brain Washington University School of Medicine in St. Louis - Washington University School... - August 27th, 2022
- ALS Gene Therapy SynCav1 Found to Extend Survival in Mouse Model |... - ALS News Today - August 27th, 2022
- A New Kind of Chemo | The UCSB Current - The UCSB Current - August 27th, 2022
- Unraveling the mystery of who gets lung cancer and why - Genetic Literacy Project - June 16th, 2022
- How diet and the microbiome affect colorectal cancer - EurekAlert - June 16th, 2022
- Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear... - May 20th, 2022
- Money on the Move: SwanBio, Remix, Locus, Mirvie and More - BioSpace - May 20th, 2022
- DiNAQOR Opens DiNAMIQS Subsidiary to Partner with Gene Therapy Companies Bringing New Treatments to Patients - PR Newswire - May 20th, 2022
- Brain tumor growth may be halted with breast cancer drug - Medical News Today - May 20th, 2022
- LogicBio Therapeutics to Present at HC Wainwright Global Investment Conference - PR Newswire - May 20th, 2022
- Genascence Announces Data From Phase 1 Clinical Trial on GNSC-001, Company's Lead Program in Osteoarthritis, Presented at American Society of Gene... - May 20th, 2022
- Encoded Therapeutics Presents Nonclinical Data Showing Genomic Medicine Platform Yields Selective Expression to Optimize Gene Therapy Performance at... - May 20th, 2022
- California, Other States to Cover Rapid WGS of Newborns Under Medicaid, but Questions of Access Loom - GenomeWeb - May 20th, 2022
- Researchers Identify Role of 'Sonic the Hedgehog' Gene in Bone Repair - BioSpace - May 20th, 2022
- Targeting the Uneven Burden of Kidney Disease on Black Americans - The New York Times - May 20th, 2022
- ASC Therapeutics, U Mass Medical School, and the Clinic for Special Children Announce Podium Presentation of Safety and Efficacy in Murine and Bovine... - May 20th, 2022
- UC Davis Looks to Expand Genetic Breast Cancer Risk Education, Outreach for Hispanic Women - Precision Oncology News - May 20th, 2022
- Fly Researchers Find Another Layer to the Code of Life - Duke Today - May 20th, 2022
- CANbridge-UMass Chan Medical School Gene Therapy Research Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business... - May 20th, 2022
- Omicron BA.4 and BA.5: What to know about the new variants - Medical News Today - May 20th, 2022
- Krystal Biotech to Present Additional Data on B-VEC from the GEM-3 Phase 3 Study at the Society for Investigative Dermatology Annual Meeting -... - May 20th, 2022
- FDA approves Lilly's Mounjaro (tirzepatide) injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2... - May 20th, 2022
- Elucidating the developmental origin of life-sustaining adrenal glands | Penn Today - Penn Today - May 20th, 2022
- 5 questions facing gene therapy in 2022 - BioPharma Dive - January 17th, 2022
- In a First, Man Receives a Heart From a Genetically Altered Pig - The New York Times - January 17th, 2022
- Antibodies, Easy Single-Cell, Genomics for All: Notes from the JP Morgan Healthcare Conference - Bio-IT World - January 17th, 2022
- Using genetics to conserve wildlife - Pursuit - January 17th, 2022
- Genetics of sudden unexplained death in children - National Institutes of Health - January 17th, 2022
- Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance - Yahoo Finance - January 17th, 2022
- Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically... - January 17th, 2022
- How The mRNA Vaccines Were Made: Halting Progress and Happy Accidents - The New York Times - January 17th, 2022
- Press Registration Is Now Open for the 2022 ACMG Annual Clinical Genetics Meeting - PRNewswire - January 17th, 2022
- A Novel Mutation in the TRPM4 Gene | RRCC - Dove Medical Press - January 17th, 2022
- Biomarkers and Candidate Therapeutic Drugs in Heart Failure | IJGM - Dove Medical Press - January 17th, 2022
- Genetic counseling program helps patients take control of their health - Medical University of South Carolina - June 24th, 2021
- One-year-old baby in UAE receives imported genetic medicine to treat rare disease - Gulf News - June 24th, 2021
- Black and non-Hispanic White Women Found to Have No Differences in Genetic Risk for Breast Cancer - Cancer Network - June 24th, 2021
- What's in your genes | The Crusader Newspaper Group - The Chicago Cusader - June 24th, 2021
- Immusoft Announces Formation of Scientific Advisory Board - Business Wire - June 24th, 2021
- Arrowhead Presents Positive Interim Clinical Data on ARO-HSD Treatment in Patients with Suspected NASH at EASL International Liver Congress - Business... - June 24th, 2021
- Pacific Biosciences and Rady Children's Institute for Genomic Medicine Announce its First Research Collaboration for Whole - GlobeNewswire - June 24th, 2021
- Despite the challenges of COVID-19, Yale-PCCSM section members continued their work on scientific papers - Yale School of Medicine - June 24th, 2021
- Veritas Intercontinental: Genetics makes it possible to identify cardiovascular genetic risk and prevent cardiac accidents such as those that have... - June 24th, 2021
- New Research Uncovers How Cancers with Common Gene Mutation Develop Resistance to Targeted Drugs - Newswise - June 24th, 2021
- Celebrate the Third Annual Medical Genetics Awareness Week April 13-16, 2021 - PRNewswire - February 14th, 2021
- How will WNY fare in the race between vaccines and coronavirus variants? - Buffalo News - February 14th, 2021
- Myriad Genetics to Participate in Multiple Upcoming Health and Technology Conferences - GlobeNewswire - February 14th, 2021
- ASCO GU 2021: The Landscape of Genetic Alterations Using ctDNA-based Comprehensive Genomic Profiling in Pat... - UroToday - February 14th, 2021
- The Human Genome and the Making of a Skeptical Biologist - Scientific American - February 14th, 2021
- Breast Cancer Gene Mutations Found in 30% of All Women - Medscape - February 1st, 2021
- Mysterious untreatable fevers once devastated whole families. This doctor discovered what caused them - CNN - February 1st, 2021
- CCMB team identifies variants of genes that metabolise drugs - BusinessLine - February 1st, 2021
- NeuBase Therapeutics Announces Acquisition of Gene Modulating Technology from Vera Therapeutics - GlobeNewswire - February 1st, 2021
- Copy number variations linked to autism have diverse but overlapping effects - Spectrum - February 1st, 2021
- Genomes, Maps, And How They Affect You - IFLScience - February 1st, 2021
- SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected - PRNewswire - February 1st, 2021
- Are Phages Overlooked Mediators of Health and Disease? - The Scientist - February 1st, 2021
- When Your Chance for a Covid Shot Comes, Dont Worry About the Numbers - Kaiser Health News - February 1st, 2021
- Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and... - February 1st, 2021
- The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene MutationExtraordinary Results With Sotorasib - SurvivorNet - February 1st, 2021
- Genetic Testing: MedlinePlus - January 29th, 2021
- 21 Common Genetic Disorders: Types, Symptoms, Causes ... - January 29th, 2021
- Genetic Counseling Online Course - School of Medicine ... - January 29th, 2021